79263465 - BIONTECH

Information

  • Trademark
  • 79263465
  • Serial Number
    79263465
  • Registration Number
    6066335
  • Filing Date
    April 05, 2019
    5 years ago
  • Registration Date
    June 02, 2020
    4 years ago
  • Transaction Date
    April 15, 2022
    2 years ago
  • Status Date
    June 02, 2020
    4 years ago
  • Published for Opposition Date
    March 17, 2020
    4 years ago
  • Location Date
    June 02, 2020
    4 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    HARDY LUDLOW, TARAH KI
  • Attorney Docket Number
    108166.0002
    Attorney Name
    Catherine C. Miller
    Law Office Assigned Location Code
    M10
  • Owners
Mark Drawing Code
5000
Mark Identification
BIONTECH
Case File Statements
  • DM0000: The mark consists of the stylized wording "BIONTECH".
  • GS0051: Pharmaceutical and veterinary preparations, namely, preparations for the prevention and treatment of proliferative diseases, cancers, infectious diseases, autoimmune diseases, except vitamin preparations, mineral food supplements, probiotics, omega 3 preparations, dietetic substances and food supplements for medical and non-medical purposes; vaccines, namely, DNA-based and RNA-based vaccines, adjuvant preparations for use with vaccines, nucleic acids sequences, proteins, and chemical reagents for medical and veterinary purposes, protein conjugates, peptides featuring antibodies and tumour markers; cell-based immunotherapeutic treatment by way of genetically modified cells, medicated serums for the treatment of proliferating diseases, cancers, infectious diseases, and autoimmune diseases, attenuated viruses and particles similar to viruses, namely, encapsulated nucleic acids; diagnostic reagents and diagnostic preparations for medical purposes
  • CC0000: Color is not claimed as a feature of the mark.
  • GS0011: Chemicals used in industry and science, in particular for use in biotechnology, pharmaceutics, medicine and veterinary medicine
  • GS0441: Medical services; providing medical care services and consultation related thereto; urgent medical care centers; pharmaceutical and medical consultancy; providing healthcare information and advisory services in the healthcare field; medical consultation services featuring preparation of reports relating to medical and pharmaceutical services; medical and pharmaceutical consultation; all the aforesaid services other than in the field of bione therapy or other types of therapy combined with bione therapy
  • GS0421: Scientific research and development in the field of molecular biology, biotechnology, pharmaceutics, immunology and oncology, in particular research and development in the field of medical and veterinary diagnostics and therapy using molecular biological, genetic engineering and biotechnological methods, and scientific research related to screening for pharmaceutically active compounds; scientific research and development of diagnostic methods and test processes; scientific research and development related to technical planning and conducting of projects in the field of the supplying of medicines; scientific consultancy services in the field of research and development of therapies and medical preparations; providing of scientific expertise in the nature of scientific study and research in the field of medicine; scientific research and development for medical and veterinary purposes; conducting and evaluating medical and pharmaceutical studies, namely, testing, analysis and evaluation of goods/services of others to determine conformity with certification standards
Case File Event Statements
  • 4/15/2022 - 2 years ago
    28 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 10/18/2020 - 3 years ago
    27 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 9/28/2020 - 3 years ago
    26 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 9/28/2020 - 3 years ago
    25 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 9/2/2020 - 3 years ago
    24 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 6/2/2020 - 4 years ago
    23 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 3/17/2020 - 4 years ago
    22 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 3/17/2020 - 4 years ago
    21 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 3/13/2020 - 4 years ago
    20 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 2/26/2020 - 4 years ago
    19 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 2/26/2020 - 4 years ago
    18 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 2/26/2020 - 4 years ago
    17 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 2/13/2020 - 4 years ago
    16 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH
  • 2/11/2020 - 4 years ago
    15 - ASSIGNED TO LIE Type: ALIE
  • 2/7/2020 - 4 years ago
    14 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 2/6/2020 - 4 years ago
    13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 2/5/2020 - 4 years ago
    12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 2/5/2020 - 4 years ago
    11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 10/24/2019 - 4 years ago
    10 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH
  • 8/30/2019 - 4 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 8/15/2019 - 4 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 8/15/2019 - 4 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 7/26/2019 - 4 years ago
    6 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 7/23/2019 - 4 years ago
    5 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 7/22/2019 - 4 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 7/22/2019 - 4 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 7/22/2019 - 4 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 7/18/2019 - 4 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR